• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二磷酸腺苷刺激不依赖血管内皮生长因子的脉络膜内皮细胞增殖:抗血管内皮生长因子治疗的潜在逃逸机制

Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy.

作者信息

Biswas Nilima, Mori Tommaso, Ragava Chetty Nagaraj Naresh Kumar, Xin Hong, Diemer Tanja, Li Pin, Su Yongxuan, Piermarocchi Carlo, Ferrara Napoleone

机构信息

Department of Pathology, University of California San Diego, La Jolla, CA 92093.

Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093.

出版信息

Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2418752122. doi: 10.1073/pnas.2418752122. Epub 2025 Jan 21.

DOI:10.1073/pnas.2418752122
PMID:39835893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11789014/
Abstract

We hypothesized that a strategy employing tissue-specific endothelial cells (EC) might facilitate the identification of tissue- or organ-specific vascular functions of ubiquitous metabolites. An unbiased approach was employed to identify water-soluble small molecules with mitogenic activity on choroidal EC. We identified adenosine diphosphate (ADP) as a candidate, following biochemical purification from mouse EL4 lymphoma extracts. ADP stimulated the growth of bovine choroidal EC (BCEC) and other bovine or human eye-derived EC. ADP induced rapid phosphorylation of extracellular signal-regulated kinase in a dose- and time-dependent manner. ADP-induced BCEC proliferation could be blocked by pretreatment with specific antagonists of the purinergic receptor P2Y1 but not with a vascular endothelial growth factor (VEGF) inhibitor, indicating that the EC mitogenic effects of ADP are not mediated by stimulation of the VEGF pathway. Intravitreal administration of ADP expanded the neovascular area in a mouse model of choroidal neovascularization. Single-cell transcriptomics from human choroidal datasets show the expression of P2RY1, but not other ADP receptors, in EC with a pattern similar to VEGFR2. Although ADP has been reported to be a growth inhibitor for vascular EC, here we describe its growth-stimulating effects for BCEC and other eye-derived EC.

摘要

我们假设,采用组织特异性内皮细胞(EC)的策略可能有助于识别普遍存在的代谢物的组织或器官特异性血管功能。我们采用一种无偏倚的方法来鉴定对脉络膜EC具有促有丝分裂活性的水溶性小分子。从小鼠EL4淋巴瘤提取物中进行生化纯化后,我们鉴定出二磷酸腺苷(ADP)为候选物。ADP刺激牛脉络膜EC(BCEC)以及其他牛或人眼源性EC的生长。ADP以剂量和时间依赖性方式诱导细胞外信号调节激酶的快速磷酸化。用嘌呤能受体P2Y1的特异性拮抗剂预处理可阻断ADP诱导的BCEC增殖,但血管内皮生长因子(VEGF)抑制剂则不能,这表明ADP对EC的促有丝分裂作用不是通过刺激VEGF途径介导的。在脉络膜新生血管小鼠模型中,玻璃体内注射ADP可扩大新生血管区域。来自人类脉络膜数据集的单细胞转录组学显示,在EC中P2RY1而非其他ADP受体的表达模式与VEGFR2相似。尽管据报道ADP是血管EC的生长抑制剂,但在此我们描述了其对BCEC和其他眼源性EC的生长刺激作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/97c03028a403/pnas.2418752122fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/b08feb48b3fd/pnas.2418752122fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/3db0fb1febc4/pnas.2418752122fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/05b2de83f7ec/pnas.2418752122fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/36ae99e8b171/pnas.2418752122fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/4b896c7ac455/pnas.2418752122fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/97c03028a403/pnas.2418752122fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/b08feb48b3fd/pnas.2418752122fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/3db0fb1febc4/pnas.2418752122fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/05b2de83f7ec/pnas.2418752122fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/36ae99e8b171/pnas.2418752122fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/4b896c7ac455/pnas.2418752122fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e77/11789014/97c03028a403/pnas.2418752122fig06.jpg

相似文献

1
Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy.二磷酸腺苷刺激不依赖血管内皮生长因子的脉络膜内皮细胞增殖:抗血管内皮生长因子治疗的潜在逃逸机制
Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2418752122. doi: 10.1073/pnas.2418752122. Epub 2025 Jan 21.
2
CBX7 promotes choroidal neovascularization by activating the HIF-1α/VEGF pathway in choroidal vascular endothelial cells.CBX7 通过激活脉络膜血管内皮细胞中的 HIF-1α/VEGF 通路促进脉络膜新生血管形成。
Exp Eye Res. 2024 Oct;247:110057. doi: 10.1016/j.exer.2024.110057. Epub 2024 Aug 22.
3
Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration.Thy-1调节血管内皮生长因子介导的脉络膜内皮细胞活化和迁移:对新生血管性年龄相关性黄斑变性的影响。
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5525-5534. doi: 10.1167/iovs.16-19691.
4
Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.YAP的抑制通过抑制内皮细胞增殖改善脉络膜新生血管形成。
Mol Vis. 2018 Jan 31;24:83-93. eCollection 2018.
5
Nucleolin down-regulation is involved in ADP-induced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells.核仁素下调参与了二磷酸腺苷(ADP)诱导的血管内皮细胞S期细胞周期阻滞和细胞凋亡。
PLoS One. 2014 Oct 7;9(10):e110101. doi: 10.1371/journal.pone.0110101. eCollection 2014.
6
Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.视网膜中CCR3的抑制在脉络膜新生血管小鼠模型中诱导视网膜细胞死亡。
PLoS One. 2016 Jun 16;11(6):e0157748. doi: 10.1371/journal.pone.0157748. eCollection 2016.
7
Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.阿帕替尼,一种血管内皮生长因子受体2抑制剂,可抑制小鼠病理性眼部新生血管形成。
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3592-3599. doi: 10.1167/iovs.17-21416.
8
Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization.G 蛋白信号转导激活因子 8 参与血管内皮生长因子诱导的脉络膜新生血管形成。
Sci Rep. 2019 Feb 7;9(1):1560. doi: 10.1038/s41598-018-38067-4.
9
Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro.槲皮素在体外抑制血管内皮生长因子诱导的脉络膜和视网膜血管生成。
Ophthalmic Res. 2015;53(3):109-16. doi: 10.1159/000369824. Epub 2015 Feb 7.
10
AQ4, an antitumor anthracenedione, inhibits endothelial cell proliferation and vascular endothelial growth factor secretion: implications for the therapy of ocular neovascular disorders.蒽二酮类抗肿瘤药 AQ4 可抑制内皮细胞增殖及血管内皮生长因子分泌:对眼部新生血管疾病治疗的意义
Eur J Pharmacol. 2007 Jul 30;568(1-3):68-74. doi: 10.1016/j.ejphar.2007.04.044. Epub 2007 May 6.

本文引用的文献

1
How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.选择性拮抗剂和基因改造如何有助于表征血管P2Y受体的表达和功能。
Purinergic Signal. 2025 Feb;21(1):11-22. doi: 10.1007/s11302-024-10016-z. Epub 2024 May 13.
2
Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes.急性冠状动脉综合征的抗血小板治疗指导策略。
Int J Mol Sci. 2024 Apr 3;25(7):3981. doi: 10.3390/ijms25073981.
3
Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers.
基于知识的治疗方法用于治疗三羧酸(TCA)循环缺陷型癌症。
Cold Spring Harb Perspect Med. 2024 Sep 3;14(9):a041536. doi: 10.1101/cshperspect.a041536.
4
Effect and potential mechanism of oncometabolite succinate promotes distant metastasis of colorectal cancer by activating STAT3.琥珀酸等致癌代谢物通过激活 STAT3 促进结直肠癌的远处转移及其潜在机制。
BMC Gastroenterol. 2024 Mar 14;24(1):106. doi: 10.1186/s12876-024-03195-x.
5
Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth.癌症中瓦博格效应的代谢特征:营养转运蛋白与分解代谢/合成代谢途径之间促进肿瘤生长的有效且必要的相互作用
Cancers (Basel). 2024 Jan 24;16(3):504. doi: 10.3390/cancers16030504.
6
Editorial - Purinergic signalling: 50 years.社论 - 嘌呤能信号传导:50年
Neuropharmacology. 2024 Mar 1;245:109826. doi: 10.1016/j.neuropharm.2023.109826. Epub 2023 Dec 20.
7
Potent P2Y Inhibitor Monotherapy for Acute Coronary Syndrome.强效P2Y抑制剂单药治疗急性冠状动脉综合征
Circ J. 2025 Feb 25;89(3):272-280. doi: 10.1253/circj.CJ-23-0750. Epub 2023 Nov 7.
8
Pharmacological characterization of P2Y receptor subtypes - an update.P2Y 受体亚型的药理学特征——更新。
Purinergic Signal. 2024 Apr;20(2):99-108. doi: 10.1007/s11302-023-09963-w. Epub 2023 Sep 12.
9
Purine and purinergic receptors in health and disease.健康与疾病中的嘌呤及嘌呤能受体
MedComm (2020). 2023 Sep 7;4(5):e359. doi: 10.1002/mco2.359. eCollection 2023 Oct.
10
Comprehensive analysis of P2Y family genes expression, immune characteristics, and prognosis in pan-cancer.泛癌中P2Y家族基因表达、免疫特征及预后的综合分析
Transl Oncol. 2023 Nov;37:101776. doi: 10.1016/j.tranon.2023.101776. Epub 2023 Sep 4.